Translating tolerogenic therapies to the clinic - Where do we stand and what are the barriers?

Stephen P. Cobbold; Xian C. Li

doi:10.3389/fimmu.2012.00317

Translating tolerogenic therapies to the clinic - Where do we stand and what are the barriers?

Stephen P. Cobbold, Xian C. Li

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Article number	Article 317
Journal	Frontiers in immunology
Volume	3
Issue number	OCT
DOIs	https://doi.org/10.3389/fimmu.2012.00317
State	Published - 2012

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Divisions

Abdominal Transplant

Access to Document

10.3389/fimmu.2012.00317

Cite this

@article{5a7979f08753456eb8f8126d2f75f1ca,

title = "Translating tolerogenic therapies to the clinic - Where do we stand and what are the barriers?",

author = "Cobbold, \{Stephen P.\} and Li, \{Xian C.\}",

year = "2012",

doi = "10.3389/fimmu.2012.00317",

language = "English (US)",

volume = "3",

journal = "Frontiers in immunology",

issn = "1664-3224",